VeraSci

Jan 19, 2021

VeraSci Partners with ActiGraph to Expand the Use of Wearables in Clinical Trials

Dec 18, 2020

VeraSci Sees Continued Growth Despite COVID-19 Challenges Faced by Clinical Trials Industry

Dec 08, 2020

Study Supporting Effectiveness of the Placebo-Control Reminder Script (PCRS) Published in Neuropsychopharmacology

Jul 14, 2020

Neurostatus-EDSS for Pathway: Improved MS outcome assessment capabilities are now available on the VeraSci eCOA Platform

Feb 04, 2020

VeraSci Global Language Solutions Are Now ISO Certified

Dec 04, 2019

VeraSci's Innovation Lab Launches Wearable Technology Validation Study

Sep 05, 2019

VeraSci Receives FDA Grant to Support Qualification of the Virtual Reality Functional Capacity Assessment Tool (VRFCAT)

Sep 03, 2019

VeraSci's Virtual Reality Functional Capacity Assessment Tool (VRFCAT) Accepted into the FDA's Clinical Outcome Assessment (COA) Qualification Program

May 09, 2019

VeraSci Welcomes William P. Horan, PhD as VP of Clinical Science

Apr 09, 2019

Leading Provider of Innovative Scientific and Technology Services Welcomes Mark Skeen, MD as Senior Medical Scientist

Dec 06, 2018

Significant Enhancements Announced for Pathway, VeraSci's Proprietary eCOA Platform

Oct 12, 2018

NeuroCog Trials is now VeraSci